Nascent Biotech Inc (NBIO) Return on Equity ROE from the first quarter 2025 to first quarter 2024 and annually, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nascent Biotech Inc   (NBIO)

Nascent Biotech Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nascent Biotech Inc in the first quarter 2025?
Due to the lack of equity, it was not possible to calculate Nascent Biotech Inc 's return on equity (ROE) in its first quarter 2025

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2024)
I. Quarter		 (Mar 31 2024)
IV. Quarter		 (Dec 31 2023)
III. Quarter		 (Sep 30 2023)
II. Quarter		 (Jun 30 2023)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -2 -2 -2 -3 -2
Return On Equity (TTM) - - - - -
NBIO's Total Ranking # # # # #
Equity (TTM) in Millions -1 0 0 0 -1
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to NBIO Management Effectiveness >> NBIO's 5 Years Annual ROE >> Compare NBIO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





NBIO Annual Return On Equity (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020
Total Equity in Millions 0 -1 -1 0 -3
Y / Y Equity Change - - - - -
Net Income in Millions -2 -3 0 -1 -4
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to NBIO Management Effectiveness >> NBIO's 5 Years Annual ROE >> Compare NBIO ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NBIO's' Return on Equity at Yahoo Finance
NBIO's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NBIO's Competitors
Subscribers only: Roe for Nascent Biotech Inc 's Suppliers
Subscribers only: Return On Equity for NBIO's Customers




Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector ROE
Inhibrx Biosciences Inc   1,617.60 %
Glucotrack Inc   825.27 %
Ir med Inc   749.30 %
Hca Healthcare Inc   658.22 %
Longduoduo Co Ltd  652.11 %
Lifecore Biomedical Inc   428.61 %
WEED, INC.  238.52 %
Biomx Inc  209.80 %

Date modified: 2026-09-08T15:11:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.